BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 32648842)

  • 21. Focusing on the brighter side of Sevoflurane: Realizing true potential of an anesthetic agent as a regulator of cell signaling pathways and microRNAs in different cancers.
    Qureshi MZ; Attar R; Javed A; Sabitaliyevich UY; Adylova A; Konysbayevna KK; Buha A; Sohail MI; Aras A
    Cell Mol Biol (Noisy-le-grand); 2019 Dec; 65(8):7-10. PubMed ID: 32133979
    [TBL] [Abstract][Full Text] [Related]  

  • 22. How sesquiterpenes modulate signaling cascades in cancers.
    Jabeen S; Qureshi MZ; Attar R; Aslam A; Kanwal S; Khalid S; Qureshi JM; Aras Perk A; Farooqi AA; Ismail M
    Cell Mol Biol (Noisy-le-grand); 2016 Jun; 62(7):110-7. PubMed ID: 27453282
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Potential Therapeutic Targets of Quercetin, a Plant Flavonol, and Its Role in the Therapy of Various Types of Cancer through the Modulation of Various Cell Signaling Pathways.
    Almatroodi SA; Alsahli MA; Almatroudi A; Verma AK; Aloliqi A; Allemailem KS; Khan AA; Rahmani AH
    Molecules; 2021 Mar; 26(5):. PubMed ID: 33804548
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Regulation of death receptors--relevance in cancer therapies.
    de Thonel A; Eriksson JE
    Toxicol Appl Pharmacol; 2005 Sep; 207(2 Suppl):123-32. PubMed ID: 16126242
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Regulation of Cell Signaling Pathways and Non-Coding RNAs by Baicalein in Different Cancers.
    Farooqi AA; Kapanova G; Kalmakhanov S; Tanbayeva G; Zhakipbekov KS; Rakhmetova VS; Syzdykbayev MK
    Int J Mol Sci; 2022 Jul; 23(15):. PubMed ID: 35955525
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Recent advances in understanding the cell death pathways activated by anticancer therapy.
    Kim R
    Cancer; 2005 Apr; 103(8):1551-60. PubMed ID: 15742333
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Vitamin D as a Novel Regulator of Tumor Metabolism: Insights on Potential Mechanisms and Implications for Anti-Cancer Therapy.
    Abu El Maaty MA; Wölfl S
    Int J Mol Sci; 2017 Oct; 18(10):. PubMed ID: 29048387
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Regulation of Cell-Signaling Pathways by Berbamine in Different Cancers.
    Farooqi AA; Wen R; Attar R; Taverna S; Butt G; Xu B
    Int J Mol Sci; 2022 Mar; 23(5):. PubMed ID: 35269900
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Recent updates on true potential of an anesthetic agent as a regulator of cell signaling pathways and non-coding RNAs in different cancers: Focusing on the brighter side of propofol.
    Farooqi AA; Adylova A; Sabitaliyevich UY; Attar R; Sohail MI; Yilmaz S
    Gene; 2020 May; 737():144452. PubMed ID: 32044408
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Oleanolic Acid Alters Multiple Cell Signaling Pathways: Implication in Cancer Prevention and Therapy.
    Žiberna L; Šamec D; Mocan A; Nabavi SF; Bishayee A; Farooqi AA; Sureda A; Nabavi SM
    Int J Mol Sci; 2017 Mar; 18(3):. PubMed ID: 28300756
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Regulation of signaling pathways by tanshinones in different cancers.
    Lin X; Qureshi MZ; Romero MA; Khalid S; Aras A; Ozbey U; Farooqi AA
    Cell Mol Biol (Noisy-le-grand); 2017 Sep; 63(9):53-58. PubMed ID: 28980934
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Targeting the RAS-dependent chemoresistance: The Warburg connection.
    Serna-Blasco R; Sanz-Álvarez M; Aguilera Ó; García-Foncillas J
    Semin Cancer Biol; 2019 Feb; 54():80-90. PubMed ID: 29432815
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inhibition of TGFβ signaling and its implications in anticancer treatments.
    Calone I; Souchelnytskyi S
    Exp Oncol; 2012; 34(1):9-16. PubMed ID: 22453142
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The roadmap of TRAIL apoptotic pathway-targeted cancer therapies: What is next?
    Bellail AC; Hao C
    Expert Rev Anticancer Ther; 2012 May; 12(5):547-9. PubMed ID: 22594889
    [No Abstract]   [Full Text] [Related]  

  • 35. New paradigms in anticancer therapy: targeting multiple signaling pathways with kinase inhibitors.
    Faivre S; Djelloul S; Raymond E
    Semin Oncol; 2006 Aug; 33(4):407-20. PubMed ID: 16890796
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Novel Anti-CRR9/CLPTM1L Antibodies with Antitumorigenic Activity Inhibit Cell Surface Accumulation, PI3K Interaction, and Survival Signaling.
    Puskás LG; Mán I; Szebeni G; Tiszlavicz L; Tsai S; James MA
    Mol Cancer Ther; 2016 May; 15(5):985-97. PubMed ID: 26939707
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Vitamin C Attenuates Sodium Fluoride-Induced Mitochondrial Oxidative Stress and Apoptosis via Sirt1-SOD2 Pathway in F9 Cells.
    Peng W; Xu S; Zhang J; Zhang Y
    Biol Trace Elem Res; 2019 Sep; 191(1):189-198. PubMed ID: 30565018
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cytoprotective and regulatory functions of glutathione S-transferases in cancer cell proliferation and cell death.
    Singh S
    Cancer Chemother Pharmacol; 2015 Jan; 75(1):1-15. PubMed ID: 25143300
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Druggable signaling proteins.
    Sioud M; Leirdal M
    Methods Mol Biol; 2007; 361():1-24. PubMed ID: 17172705
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Vitamin C antagonizes the cytotoxic effects of antineoplastic drugs.
    Heaney ML; Gardner JR; Karasavvas N; Golde DW; Scheinberg DA; Smith EA; O'Connor OA
    Cancer Res; 2008 Oct; 68(19):8031-8. PubMed ID: 18829561
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.